The Death of Celsion?
ThinkstockThe biotech sector is full of companies which will have great wins and horrible flops. The latter is the case today for Celsion (NASDAQ: CLSN). In fact, if you just look at the stock…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 310Deutsche Bank Raises Targets and Estimates on Hospitals and Health Care Facility Stocks (DB, THC, HCA, VHS, CYH, HMA, UHS, LPNT)
ThinkstockHospitals and health care facilities to most of us are like the police station. You are glad they are there, but you don’t really want to go. When it comes to investing in this…
Boston Scientific Turnaround Finally Begins to Take Shape
ThinkstockBoston Scientific Corp. (NYSE: BSX) is trading higher today after earnings and after a restructuring direction has been set. Unfortunately for its investors, Boston Scientific remains a story of an endless turnaround that just…
Keryx Gets Back on the Map
ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) has not been a household name in biotech investing, but the move on news on Monday has put the company on the map. After shares are up almost 95%…
Biogen Idec Results Mixed
ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) reported fourth-quarter and full-year 2012 results before markets opened this morning. For the quarter, the biotech firm posted adjusted diluted earnings per share (EPS) of $1.40 on revenues of…
LipoScience IPO Prices Weak but Debuts Strong
ThinkstockLipoScience Inc. (NASDAQ: LPDX) is now open as a public company, now that its initial public offering has priced and begun trading. This was an under-the-radar IPO, and some investors may not know about…
Americans Still Astonishingly Fat
ThinkstockIf current levels of obesity tell anything about current and future health care costs and the overall risks of disease among the American population, then pessimism about them remains justified. According to new Gallup…
Arena Risk: Possible Drag on All Weight-Loss Drugs
ThinkstockArena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% on news that European…
Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)
ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only to heart disease, according…
Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)
ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However they are careful to…
UnitedHealth Earnings Good, but Not Exciting
ThinkstockUnitedHealth Group Inc. (NYSE: UNH) reported fourth-quarter and full-year 2012 results before markets opened this morning. The health insurance and benefits management firm reported diluted quarterly earnings per share (EPS) of $1.20 on revenues…
The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)
ThinkstockBack in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a battle of not only…
Forest Labs Sputters on Patent Expiration
ThinkstockForest Laboratories Inc. (NYSE: FRX) reported third-quarter fiscal 2013 results before markets opened this morning. The drug maker and marketer reported an adjusted diluted earnings per share (EPS) loss of $0.21 on total revenues…
Walmart Looking at Health Insurance Exchange
ThinkstockRetail behemoth Wal-Mart Stores Inc. (NYSE: WMT) is exploring the possibility of offering health insurance to small-business owners by setting up a health insurance exchange. The exchanges, which were created under the provisions of…
More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)
ThinkstockCancer ranks on the list of global killers as number two. Over the years, great strides have been made not only in cancer treatment but in survival rates for many different forms of the disease.…